nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A8—Adefovir Dipivoxil—hepatitis B	0.291	0.475	CbGbCtD
Minocycline—SLC22A6—Adefovir Dipivoxil—hepatitis B	0.203	0.331	CbGbCtD
Minocycline—SLC22A6—Lamivudine—hepatitis B	0.119	0.194	CbGbCtD
Minocycline—CYCS—blood plasma—hepatitis B	0.0131	0.149	CbGeAlD
Minocycline—CASP3—blood plasma—hepatitis B	0.0112	0.127	CbGeAlD
Minocycline—IL1B—blood plasma—hepatitis B	0.00898	0.102	CbGeAlD
Minocycline—MMP9—blood plasma—hepatitis B	0.00748	0.0848	CbGeAlD
Minocycline—CASP1—blood—hepatitis B	0.00499	0.0566	CbGeAlD
Minocycline—CYCS—blood—hepatitis B	0.00481	0.0545	CbGeAlD
Minocycline—CYCS—Gemcitabine—Lamivudine—hepatitis B	0.00465	1	CbGdCrCtD
Minocycline—CASP3—blood—hepatitis B	0.00412	0.0467	CbGeAlD
Minocycline—CASP1—liver—hepatitis B	0.0039	0.0443	CbGeAlD
Minocycline—CYCS—liver—hepatitis B	0.00376	0.0426	CbGeAlD
Minocycline—IL1B—blood—hepatitis B	0.00329	0.0373	CbGeAlD
Minocycline—CASP3—liver—hepatitis B	0.00322	0.0365	CbGeAlD
Minocycline—MMP9—blood—hepatitis B	0.00274	0.0311	CbGeAlD
Minocycline—IL1B—liver—hepatitis B	0.00257	0.0291	CbGeAlD
Minocycline—VEGFA—liver—hepatitis B	0.00253	0.0287	CbGeAlD
Minocycline—ALOX5—blood—hepatitis B	0.00217	0.0246	CbGeAlD
Minocycline—MMP9—liver—hepatitis B	0.00214	0.0243	CbGeAlD
Minocycline—SLC22A11—liver—hepatitis B	0.00203	0.023	CbGeAlD
Minocycline—SLC22A7—liver—hepatitis B	0.00198	0.0225	CbGeAlD
Minocycline—ALOX5—liver—hepatitis B	0.00169	0.0192	CbGeAlD
Minocycline—SLC22A8—blood—hepatitis B	0.00147	0.0166	CbGeAlD
Minocycline—Methacycline—ALB—hepatitis B	0.00144	0.695	CrCbGaD
Minocycline—Tetracycline—ALB—hepatitis B	0.000631	0.305	CrCbGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—IL6—hepatitis B	0.000155	0.000529	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TGFB1—hepatitis B	0.000153	0.000521	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—NFKB1—hepatitis B	0.000152	0.000521	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—hepatitis B	0.000152	0.000519	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000152	0.000519	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—hepatitis B	0.000151	0.000517	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000151	0.000515	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DRB1—hepatitis B	0.000151	0.000515	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HNF4A—hepatitis B	0.000151	0.000514	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL2—hepatitis B	0.00015	0.000512	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—NFKB1—hepatitis B	0.000147	0.000502	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—NFKB1—hepatitis B	0.000147	0.000501	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000146	0.0005	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—hepatitis B	0.000146	0.000499	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNGR1—hepatitis B	0.000146	0.000498	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IL6—hepatitis B	0.000145	0.000496	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL6—hepatitis B	0.000143	0.000487	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—hepatitis B	0.000142	0.000486	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000142	0.000484	CbGpPWpGaD
Minocycline—CASP1—Immune System—HSPA5—hepatitis B	0.000141	0.00048	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TGFB1—hepatitis B	0.00014	0.000478	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—hepatitis B	0.000139	0.000474	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000139	0.000473	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB1—hepatitis B	0.000139	0.000473	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000138	0.000472	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—hepatitis B	0.000138	0.000472	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—NFKB1—hepatitis B	0.000138	0.000471	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—hepatitis B	0.000138	0.000471	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000138	0.00047	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—CTNNB1—hepatitis B	0.000136	0.000464	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TLR4—hepatitis B	0.000136	0.000463	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—hepatitis B	0.000135	0.000461	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—hepatitis B	0.000135	0.00046	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—hepatitis B	0.000134	0.000457	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DPB1—hepatitis B	0.000133	0.000454	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—hepatitis B	0.000133	0.000453	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN1A—hepatitis B	0.000133	0.000453	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	0.000132	0.000451	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—NFKB1—hepatitis B	0.000132	0.000449	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HNF4A—hepatitis B	0.000131	0.000446	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—hepatitis B	0.000131	0.000446	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SAG—hepatitis B	0.000129	0.000441	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RIT2—hepatitis B	0.000129	0.000441	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—hepatitis B	0.000129	0.000441	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—CTNNB1—hepatitis B	0.000128	0.000438	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR2—hepatitis B	0.000128	0.000436	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000127	0.000434	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—hepatitis B	0.000127	0.000433	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNB1—hepatitis B	0.000127	0.000433	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—hepatitis B	0.000126	0.000432	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—hepatitis B	0.000126	0.000431	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000126	0.00043	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—hepatitis B	0.000126	0.000429	CbGpPWpGaD
Minocycline—IL1B—Immune System—MX1—hepatitis B	0.000125	0.000428	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—hepatitis B	0.000125	0.000426	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNA1—hepatitis B	0.000124	0.000423	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—hepatitis B	0.000123	0.000421	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—CDKN1A—hepatitis B	0.000123	0.000419	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—hepatitis B	0.000123	0.000419	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PTEN—hepatitis B	0.000122	0.000418	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—hepatitis B	0.000119	0.000405	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—F2—hepatitis B	0.000117	0.000399	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—hepatitis B	0.000117	0.000399	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD14—hepatitis B	0.000115	0.000393	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNA2—hepatitis B	0.000115	0.000393	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000115	0.000392	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—hepatitis B	0.000115	0.000392	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000115	0.000391	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000114	0.000389	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000114	0.000389	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HSPA5—hepatitis B	0.000112	0.000381	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—hepatitis B	0.000112	0.000381	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNG—hepatitis B	0.00011	0.000376	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—hepatitis B	0.000109	0.000373	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000109	0.000371	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—hepatitis B	0.000107	0.000366	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000107	0.000365	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKR1B1—hepatitis B	0.000107	0.000364	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—hepatitis B	0.000105	0.000357	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000103	0.000352	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GGT2—hepatitis B	0.000102	0.000349	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000102	0.000347	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.000101	0.000344	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IFNB1—hepatitis B	0.000101	0.000344	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP2A6—hepatitis B	0.000101	0.000343	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000101	0.000343	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000101	0.000343	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—CDKN1A—hepatitis B	0.0001	0.000343	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PTEN—hepatitis B	0.0001	0.000342	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.0001	0.000342	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NFKB1—hepatitis B	9.96e-05	0.00034	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL18—hepatitis B	9.83e-05	0.000336	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IFNA1—hepatitis B	9.82e-05	0.000335	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD40LG—hepatitis B	9.79e-05	0.000334	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—hepatitis B	9.79e-05	0.000334	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NFKB1—hepatitis B	9.75e-05	0.000333	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—ALB—hepatitis B	9.72e-05	0.000332	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—hepatitis B	9.69e-05	0.000331	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—hepatitis B	9.63e-05	0.000329	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—hepatitis B	9.55e-05	0.000326	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—hepatitis B	9.46e-05	0.000323	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	9.44e-05	0.000322	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—hepatitis B	9.24e-05	0.000315	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—hepatitis B	9.21e-05	0.000314	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—hepatitis B	9.19e-05	0.000314	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—NFKB1—hepatitis B	9.17e-05	0.000313	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IFNA2—hepatitis B	9.14e-05	0.000312	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—ALB—hepatitis B	9.1e-05	0.000311	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GOT2—hepatitis B	9.1e-05	0.000311	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—hepatitis B	9.03e-05	0.000308	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RIT2—hepatitis B	8.97e-05	0.000306	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SAG—hepatitis B	8.97e-05	0.000306	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ALB—hepatitis B	8.92e-05	0.000304	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—hepatitis B	8.85e-05	0.000302	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—hepatitis B	8.81e-05	0.000301	CbGpPWpGaD
Minocycline—IL1B—Immune System—HSPA5—hepatitis B	8.79e-05	0.0003	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-A—hepatitis B	8.63e-05	0.000295	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CTNNB1—hepatitis B	8.58e-05	0.000293	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	8.55e-05	0.000292	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CTNNB1—hepatitis B	8.48e-05	0.00029	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PTEN—hepatitis B	8.37e-05	0.000286	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	8.35e-05	0.000285	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	8.33e-05	0.000284	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DPB1—hepatitis B	8.3e-05	0.000283	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	8.29e-05	0.000283	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDKN1A—hepatitis B	8.29e-05	0.000283	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	8.27e-05	0.000282	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PTEN—hepatitis B	8.27e-05	0.000282	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—hepatitis B	8.26e-05	0.000282	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—ALB—hepatitis B	8.26e-05	0.000282	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NFKB1—hepatitis B	8.23e-05	0.000281	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR2—hepatitis B	7.99e-05	0.000273	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNB1—hepatitis B	7.93e-05	0.000271	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR4—hepatitis B	7.9e-05	0.00027	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2A—hepatitis B	7.89e-05	0.000269	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DRB1—hepatitis B	7.89e-05	0.000269	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—hepatitis B	7.88e-05	0.000269	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GOT1—hepatitis B	7.85e-05	0.000268	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GGT1—hepatitis B	7.85e-05	0.000268	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—hepatitis B	7.81e-05	0.000267	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SAG—hepatitis B	7.78e-05	0.000266	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RIT2—hepatitis B	7.78e-05	0.000266	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNA1—hepatitis B	7.74e-05	0.000264	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—hepatitis B	7.64e-05	0.000261	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—hepatitis B	7.58e-05	0.000259	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD14—hepatitis B	7.2e-05	0.000246	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNA2—hepatitis B	7.2e-05	0.000246	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—hepatitis B	6.94e-05	0.000237	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	6.91e-05	0.000236	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—hepatitis B	6.86e-05	0.000234	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	6.45e-05	0.00022	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN1A—hepatitis B	6.45e-05	0.00022	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—NFKB1—hepatitis B	6.4e-05	0.000219	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—hepatitis B	6.25e-05	0.000213	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2A6—hepatitis B	6.2e-05	0.000212	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	6.15e-05	0.00021	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL18—hepatitis B	6.15e-05	0.00021	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—hepatitis B	6.14e-05	0.00021	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40LG—hepatitis B	6.12e-05	0.000209	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—hepatitis B	6.12e-05	0.000209	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—hepatitis B	6.05e-05	0.000207	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—F2—hepatitis B	6.03e-05	0.000206	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—hepatitis B	5.96e-05	0.000203	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—hepatitis B	5.79e-05	0.000198	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.78e-05	0.000197	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—hepatitis B	5.76e-05	0.000197	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—hepatitis B	5.76e-05	0.000197	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	5.69e-05	0.000194	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GOT2—hepatitis B	5.6e-05	0.000191	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—hepatitis B	5.56e-05	0.00019	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-A—hepatitis B	5.4e-05	0.000184	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—hepatitis B	5.17e-05	0.000176	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—hepatitis B	5.12e-05	0.000175	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL10—hepatitis B	5.1e-05	0.000174	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—hepatitis B	5.01e-05	0.000171	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTNNB1—hepatitis B	4.94e-05	0.000169	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—hepatitis B	4.93e-05	0.000168	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRB1—hepatitis B	4.93e-05	0.000168	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GGT1—hepatitis B	4.84e-05	0.000165	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GOT1—hepatitis B	4.84e-05	0.000165	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1A—hepatitis B	4.83e-05	0.000165	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTEN—hepatitis B	4.82e-05	0.000164	CbGpPWpGaD
Minocycline—CASP1—Immune System—NFKB1—hepatitis B	4.79e-05	0.000164	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—hepatitis B	4.62e-05	0.000158	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CTNNB1—hepatitis B	4.6e-05	0.000157	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NFKB1—hepatitis B	4.47e-05	0.000152	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.41e-05	0.000151	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—hepatitis B	4.39e-05	0.00015	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—hepatitis B	4.2e-05	0.000143	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—hepatitis B	4.18e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—hepatitis B	4.06e-05	0.000139	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—hepatitis B	4.02e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CTNNB1—hepatitis B	4e-05	0.000136	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR5—hepatitis B	3.95e-05	0.000135	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—hepatitis B	3.93e-05	0.000134	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NFKB1—hepatitis B	3.88e-05	0.000132	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—hepatitis B	3.72e-05	0.000127	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—hepatitis B	3.6e-05	0.000123	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL10—hepatitis B	3.54e-05	0.000121	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—hepatitis B	3.53e-05	0.00012	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—hepatitis B	3.48e-05	0.000119	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—hepatitis B	3.47e-05	0.000119	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—hepatitis B	3.41e-05	0.000116	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—F2—hepatitis B	3.39e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—hepatitis B	3.23e-05	0.00011	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—hepatitis B	3.2e-05	0.000109	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTEN—hepatitis B	3.19e-05	0.000109	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—hepatitis B	3.17e-05	0.000108	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTNNB1—hepatitis B	3.09e-05	0.000105	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL10—hepatitis B	3.07e-05	0.000105	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1A—hepatitis B	3.02e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—hepatitis B	3.02e-05	0.000103	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTEN—hepatitis B	3.01e-05	0.000103	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—hepatitis B	3.01e-05	0.000103	CbGpPWpGaD
Minocycline—IL1B—Immune System—NFKB1—hepatitis B	3e-05	0.000102	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—hepatitis B	2.94e-05	0.0001	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—hepatitis B	2.8e-05	9.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR5—hepatitis B	2.75e-05	9.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—hepatitis B	2.61e-05	8.9e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—hepatitis B	2.57e-05	8.79e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—hepatitis B	2.43e-05	8.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR5—hepatitis B	2.38e-05	8.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—F2—hepatitis B	2.36e-05	8.04e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—hepatitis B	2.28e-05	7.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CTNNB1—hepatitis B	2.21e-05	7.53e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1A—hepatitis B	2.15e-05	7.36e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTEN—hepatitis B	2.15e-05	7.34e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NFKB1—hepatitis B	2.14e-05	7.3e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—F2—hepatitis B	2.04e-05	6.98e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTEN—hepatitis B	1.96e-05	6.7e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—hepatitis B	1.88e-05	6.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—hepatitis B	1.78e-05	6.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—hepatitis B	1.59e-05	5.42e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CTNNB1—hepatitis B	1.53e-05	5.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1A—hepatitis B	1.5e-05	5.11e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTEN—hepatitis B	1.49e-05	5.1e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NFKB1—hepatitis B	1.49e-05	5.07e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—hepatitis B	1.47e-05	5.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—hepatitis B	1.38e-05	4.7e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—hepatitis B	1.34e-05	4.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CTNNB1—hepatitis B	1.33e-05	4.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1A—hepatitis B	1.3e-05	4.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTEN—hepatitis B	1.3e-05	4.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NFKB1—hepatitis B	1.29e-05	4.4e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—hepatitis B	1.24e-05	4.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—hepatitis B	1.07e-05	3.67e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—hepatitis B	1.02e-05	3.48e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—hepatitis B	9.32e-06	3.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—hepatitis B	8.84e-06	3.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—hepatitis B	8.09e-06	2.76e-05	CbGpPWpGaD
